We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Judge Sets Deadline for Post-Trial Briefs In Zyprexa Case

Law360 (March 3, 2004, 12:00 AM EST) -- A federal judge has given both sides in the patent trial over Eli Lilly's Zyprexa schizophrenia drug until May 12 to file all of their post-trial briefs.

U.S. District Court Judge Richard L. Young last week also extended a stay barring the sale of generic Zyprexa until a verdict is handed down.

Young set the post-trial deadlines last week, after Lilly and the two main defendants couldn't agree to a schedule on their own.

Young ordered defendants Zenith Goldline Pharmaceuticals and Dr. Reddy's Laboratories to file...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.